首页 正文

Harnessing Nanocarriers to Modulate Gut Inflammation: A New Era in IBD Management

{{output}}
Inflammatory bowel disease (IBD) is a chronic inflammatory condition affecting the gastrointestinal tract, primarily including Crohn's disease and ulcerative colitis. Current treatments rely heavily on synthetic medications and monoclonal antibodies. While th... ...